Greenwich LifeSciences Inc. (GLSI): Price and Financial Metrics
GLSI Price/Volume Stats
| Current price | $12.39 | 52-week high | $21.44 |
| Prev. close | $12.52 | 52-week low | $8.00 |
| Day low | $12.15 | Volume | 72,600 |
| Day high | $12.77 | Avg. volume | 39,169 |
| 50-day MA | $13.57 | Dividend yield | N/A |
| 200-day MA | $14.65 | Market Cap | 162.87M |
GLSI Stock Price Chart Interactive Chart >
Greenwich LifeSciences Inc. (GLSI) Company Bio
Greenwich LifeSciences, Inc. engages in the development of a breast cancer immunotherapy designed to prevent the recurrence of breast cancer following surgery. The company was founded by Eric Rothe on August 29, 2006 and is headquartered in Stafford, TX.
GLSI Price Returns
| 1-mo | -4.47% |
| 3-mo | -16.73% |
| 6-mo | -20.06% |
| 1-year | 15.69% |
| 3-year | -57.26% |
| 5-year | N/A |
| YTD | 17.78% |
| 2023 | -30.79% |
| 2022 | -37.53% |
| 2021 | -33.29% |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...